|To:||All RML Clients|
|From:||Gerald C. Miller, Ph.D., Chief of Microbiology & Immunology
Linda Strycker, MT (ASCP), Manager, Microbiology
|Date:||July 14th, 2008|
|Subject:||Replacement of ICT Cards with new Automated Fecal Occult Blood Test to Detect Colorectal Cancer|
As of July 14th 2008, Regional Medical Laboratory (RML) will no longer utilize the ICT card to test for colorectal cancer. This test will be replaced with the new automated fecal occult blood test (ICT OCCULT), an immunoassay which detects the presence of human hemoglobin using a photometric reading of the presence of an antibody-antigen complex. This immuno-chemical test provides several advantages over the old guaiac method which include ease of collection, reduction in the number of samples needed, no dietary restrictions, increased specificity for human hemoglobin and detection of hemoglobin from the colon or rectal area only.
The new ICT OCCULT test requires only one sample unlike the guaiac method test which required 3 consecutive samples in order to confirm negativity. The ICT OCCULT test also solves the problems associated with the guaiac test which have had a low rate of patient compliance due to an unpleasant collection procedure and multiple dietary restrictions. The ICT OCCULT is reported to have a higher sensitivity and specificity with reported greater detection of early stage colorectal cancer.
RML will be replacing the ICT cards with the new ICT device. Please contact your Sales Representative or Client Services if you have not received the new collection device.
|Test Highlights & References|
|Test Name:||Fecal Occult Blood Test Automated|
|Order Name:||ICT OCCULT|
|Performed:||Daily with same day reporting|
|Specimen Required:||Submit a single stool specimen collected on dowel of provided collection device|
|Transport:||Routine courier pickup or U.S. Postal service, mail in provided mailer|
|Processing:||Submit original collection device|
|Storage:||Store at room temperature up to 5 days|
|Unacceptable Condition:||Specimen collected more than 5 days prior to testing|
If you have questions, please contact Gerald C. Miller, Ph.D., Chief of Microbiology and Immunology or Linda Strycker MT (ASCP) Manager, Microbiology at 918-744-2553 or 800-722-8077.